Kodiak Sciences Inc.
KOD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $7 | $7 | $7 | $7 |
| Gross Profit | -$7 | -$7 | -$7 | -$7 |
| % Margin | – | – | – | – |
| R&D Expenses | $50 | $43 | $44 | $32 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $5 | $6 | $7 | $8 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $56 | $49 | $50 | $39 |
| Operating Income | -$62 | -$56 | -$57 | -$46 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1 | $1 | -$0 | $2 |
| Pre-Tax Income | -$61 | -$54 | -$57 | -$44 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$61 | -$54 | -$57 | -$44 |
| % Margin | – | – | – | – |
| EPS | -1.16 | -1.03 | -1.09 | -0.84 |
| % Growth | -12.6% | 5.5% | -29.8% | – |
| EPS Diluted | -1.16 | -1.03 | -1.09 | -0.84 |
| Weighted Avg Shares Out | 53 | 53 | 53 | 53 |
| Weighted Avg Shares Out Dil | 53 | 53 | 53 | 53 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $2 | $2 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $7 | $7 | $7 | $7 |
| EBITDA | -$55 | -$48 | -$51 | -$37 |
| % Margin | – | – | – | – |